Veerhuis, Robert

How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes

Blasko, I., Stampfer‐Kountchev, M., Robatscher, P., Veerhuis, R., Eikelenboom, P., & Grubeck‐Loebenstein, B. (2004) · Aging Cell

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Cited by 374

Costimulatory Effects of Interferon-γ and Interleukin-1β or Tumor Necrosis Factor α on the Synthesis of Aβ1-40 and Aβ1-42 by Human Astrocytes

Blasko, I., Veerhuis, R., Stampfer-Kountchev, M., Saurwein-Teissl, M., Eikelenboom, P., & Grubeck-Loebenstein, B. (2000) · Neurobiology of Disease

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 258

The role of complement and activated microglia in the pathogenesis of Alzheimer's disease

Eikelenboom, P., & Veerhuis, R. (1996) · Neurobiology of Aging

Alzheimer's disease research and treatmentsComplement system in diseases

Cited by 206

The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions

Brink, B. P., Veerhuis, R., Breij, E. C. W., van der Valk, P., Dijkstra, C. D., & Bö, L. (2005) · Journal of Neuropathology & Experimental Neurology

Multiple Sclerosis Research StudiesComplement system in diseases

Cited by 191

Inflammatory markers in AD and MCI patients with different biomarker profiles

Schuitemaker, A., Dik, M. G., Veerhuis, R., Scheltens, P., Schoonenboom, N. S. M., Hack, C. E., Blankenstein, M. A., & Jonker, C. (2009) · Neurobiology of Aging

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 149

Lipoprotein Receptor-Related Protein-1 Mediates Amyloid-β-Mediated Cell Death of Cerebrovascular Cells

Wilhelmus, M. M. M., Otte-Höller, I., van Triel, J. J. J., Veerhuis, R., Maat-Schieman, M. L. C., Bu, G., de Waal, R. M. W., & Verbeek, M. M. (2007) · The American Journal of Pathology

Alzheimer's disease research and treatmentsBarrier Structure and Function Studies

Cited by 138

Cyclooxygenase-1 and -2 in the Different Stages of Alzheimers Disease Pathology

Hoozemans, J., Rozemuller, J., van Haastert, E., Veerhuis, R., & Eikelenboom, P. (2008) · Current Pharmaceutical Design

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 137

Amyloid β plaque-associated proteins C1q and SAP enhance the Aβ1–42 peptide-induced cytokine secretion by adult human microglia in vitro

Veerhuis, R., Van Breemen, M. J., Hoozemans, J. J., Morbin, M., Ouladhadj, J., Tagliavini, F., & Eikelenboom, P. (2003) · Acta Neuropathologica

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Cited by 123

Binding and uptake of Aβ1‐42 by primary human astrocytes in vitro

Nielsen, H. M., Veerhuis, R., Holmqvist, B., & Janciauskiene, S. (2009) · Glia

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 96

Amyloid β Protein Primes Cultured Rat Microglial Cells for an Enhanced Phorbol 12‐Myristate 13‐Acetate‐Induced Respiratory Burst Activity

Van Muiswinkel, F. L., Veerhuis, R., & Eikelenboom, P. (1996) · Journal of Neurochemistry

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Cited by 85

Histological and Direct Evidence for the Role of Complement in the Neuroinflammation of AD

Veerhuis, R. (2011) · Current Alzheimer Research

Alzheimer's disease research and treatmentsComplement system in diseases

Cited by 80

BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology

Mulder, S. D., van der Flier, W. M., Verheijen, J. H., Mulder, C., Scheltens, P., Blankenstein, M. A., Hack, C. E., & Veerhuis, R. (2010) · Journal of Alzheimer s Disease

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 80

Early complement components in Alzheimer's disease brains

Veerhuis, R., Janssen, I., Hack, C. E., & Eikelenboom, P. (1995) · Acta Neuropathologica

Alzheimer's disease research and treatmentsComplement system in diseases

Cited by 77

Brain-specific fatty acid-binding protein is elevated in serum of patients with dementia-related diseases: Brain-specific fatty acid-binding protein in dementia

Teunissen, C. E., Veerhuis, R., De Vente, J., Verhey, F. R. J., Vreeling, F., van Boxtel, M. P. J., Glatz, J. F. C., & Pelsers, M. A. L. (2011) · European Journal of Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 74

NG2 cells, a new trail for Alzheimer’s disease mechanisms?

Nielsen, H. M., Ek, D., Avdic, U., Orbjörn, C., Hansson, O., Bank, T. N. B., Veerhuis, R., Rozemuller, A. J., Brun, A., Minthon, L., et al. (2013) · Acta Neuropathologica Communications

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 71

Amyloid-β Oligomers Relate to Cognitive Decline in Alzheimer's Disease

Jongbloed, W., Bruggink, K. A., Kester, M. I., Visser, P.-J., Scheltens, P., Blankenstein, M. A., Verbeek, M. M., Teunissen, C. E., & Veerhuis, R. (2015) · Journal of Alzheimer's Disease

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 68

Maximal COX-2 and ppRb expression in neurons occurs during early Braak stages prior to the maximal activation of astrocytes and microglia in Alzheimer's disease

Hoozemans, J. J., van Haastert, E. S., Veerhuis, R., Arendt, T., Scheper, W., Eikelenboom, P., & Rozemuller, A. J. (2005) · Journal of Neuroinflammation

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 52

ATP-binding cassette transporters P-glycoprotein and breast cancer related protein are reduced in capillary cerebral amyloid angiopathy

Carrano, A., Snkhchyan, H., Kooij, G., van der Pol, S., van Horssen, J., Veerhuis, R., Hoozemans, J., Rozemuller, A., & de Vries, H. E. (2014) · Neurobiology of Aging

Alzheimer's disease research and treatmentsDrug Transport and Resistance Mechanisms

Cited by 51

Facilitating the Validation of Novel Protein Biomarkers for Dementia: An Optimal Workflow for the Development of Sandwich Immunoassays

del Campo, M., Jongbloed, W., Twaalfhoven, H. A. M., Veerhuis, R., Blankenstein, M. A., & Teunissen, C. E. (2015) · Frontiers in Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 34